Source link : https://www.newshealth.biz/health-news/more-thyroid-cancers-found-after-starting-glp-1s-researchers-think-they-know-why/
More thyroid cancers were detected soon after starting a GLP-1 receptor agonist than other diabetes drugs, a secondary analysis of a target trial emulation of a comparative effectiveness study found. Of over 350,000 adults with type 2 diabetes, thyroid cancer risk was significantly higher within the first year after GLP-1 agonist initiation compared with SGLT2 […]
Author : News Health
Publish date : 2025-01-23 22:24:50
Copyright for syndicated content belongs to the linked Source.